Commentary: drug and vaccine pricing and innovation, what is the story?
Article Abstract:
Three papers were analyzed to investigate the practice the cost of developing new products and its effects on prices of drugs. Among the paper assessed is William S. Comanor and Stuart Schweitzer's "Determinants of Drug Prices and Expenditures".
Publisher: John Wiley & Sons, Inc.
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
Product development, Innovations, Pharmaceutical industry, Medical care, Cost of, Health care costs
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Commentary
Article Abstract:
A review of Ernst R. Berndt's "A Primer on the Economics of Re-Importation of Prescription Drugs" is provided. The impacts of price controls on research and development in the pharmaceutical industry are discussed.
Publisher: John Wiley & Sons, Inc.
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
United States, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Pharmaceutical Preparation Manufacturing, Drugs, Pharmaceutical Preparations, Metabolic Agents NEC, Metabolic Agents, Price control, Price regulations
Publication Name: Managerial & Decision Economics
Subject: Economics
ISSN: 0143-6570
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Prices and rates, Criticism and interpretation, Company pricing policy, Critical essay
Similar abstracts:
- Abstracts: Market structure and the pricing of electricity and natural gas. An empirical analysis of electricity regulation on technical changes in Texas
- Abstracts: Robust permanent income and pricing. Optimal guessing: choice in complex environments. Introduction to model uncertainty and robustness
- Abstracts: Phased-in tax cuts and economic activity. The Greenspan era: discretion, rather than rules. The road to price stability
- Abstracts: The Fed's monetary policy rule and U.S. inflation: the case of asymmetric preferences. Inflation persistence and robust monetary policy design
- Abstracts: Mergers and acquisitions in the pharmaceutical and biotech industries. Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.